The Current Ratio as of September 2024 (TTM) for Interpace Biosciences, Inc. (IDXG) is 0.53

According to Interpace Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.53. This represents a change of -16.18% compared to the average of 0.64 of the last 4 quarters.

Interpace Biosciences, Inc. (IDXG) Historical Current Ratio (quarterly & annually)

How has IDXG Current Ratio performed in the past?

The mean historical Current Ratio of Interpace Biosciences, Inc. over the last ten years is 1.09. The current 0.53 Current Ratio has changed 4.79% with respect to the historical average. Over the past ten years (40 quarters), IDXG's Current Ratio was at its highest in in the June 2018 quarter at 2.61. The Current Ratio was at its lowest in in the December 2016 quarter at 0.26.

Interpace Biosciences, Inc. (IDXG) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Interpace Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Interpace Biosciences, Inc. (IDXG) Average Current Ratio

How has IDXG Current Ratio performed in the past?

The current Current Ratio of Interpace Biosciences, Inc. (IDXG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Interpace Biosciences, Inc. (IDXG) Current Ratio vs. Peers

How is IDXG’s Current Ratio compared to its peers?

Interpace Biosciences, Inc.’s Current Ratio is less than Intelligent Bio Solutions Inc. (1.57), less than bioAffinity Technologies, Inc. (1.15), less than SeqLL Inc. (1.06), less than Biocept, Inc. (1.81), less than FONAR Corporation (9.37), less than Burning Rock Biotech Limited (3.11), less than Sera Prognostics, Inc. (2.08), less than Olink Holding AB (publ) (5.60), less than LumiraDx Limited (1.97), less than HTG Molecular Diagnostics, Inc. (1.40), less than bioAffinity Technologies, Inc. (1.15), less than Genetron Holdings Limited (1.82), less than Exagen Inc. (4.32), less than OncoCyte Corporation (1.38), less than Personalis, Inc. (3.18), less than iSpecimen Inc. (0.90), less than Trinity Biotech plc (1.78),

Build a custom stock screener for Interpace Biosciences, Inc. (IDXG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Interpace Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Interpace Biosciences, Inc. (IDXG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Interpace Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.